These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20838736)

  • 1. Studies on Fletcher trait and Fitzgerald trait. A rare chance to disclose body's defense reactions against injury.
    Saito H
    Thromb Haemost; 2010 Nov; 104(5):867-74. PubMed ID: 20838736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Fletcher factor (plasma prekallikrein) deficiency with partial deficiency of Hageman factor (factor XII): report of a case with observation on in vivo and in vitro leukocyte chemotaxis.
    Poon MC; Moore MR; Castleberry RP; Lurie A; Huang ST; Lehmeyer J
    Am J Hematol; 1982 May; 12(3):261-70. PubMed ID: 6919394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first cases of Fitzgerald factor deficiency in the Orient: three cases in one family.
    Hayashi H; Koya H; Kuroda M; Kitazima K; Kimura I; Katori M; Oh-ishi S
    Acta Haematol; 1980; 63(2):107-13. PubMed ID: 6768213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).
    Saito H; Ratnoff OD; Waldmann R; Abraham JP
    J Clin Invest; 1975 May; 55(5):1082-9. PubMed ID: 16695963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay.
    Saito H; Goldsmith GH
    Blood; 1977 Sep; 50(3):377-85. PubMed ID: 884316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.
    Poon MC; Saito H; Koopman WJ
    Blood; 1984 Jun; 63(6):1309-17. PubMed ID: 6426550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
    Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
    J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
    Donaldson VH; Kleniewski J; Saito H; Sayed JK
    J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoelectrophoretic studies of prekallikrein in human plasma.
    Hathaway WE; Christian J; McGregor R; Borden C
    Thromb Res; 1982 Feb; 25(3):267-75. PubMed ID: 6917563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
    Gordon EM; Ratnoff OD; Goldsmith GH
    J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen.
    Scicli AG; Mindroiu T; Scicli G; Carretero OA
    J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prekallikrein deficiency in man.
    Wuepper KD
    J Exp Med; 1973 Dec; 138(6):1345-55. PubMed ID: 4762550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic potential of the contact activation pathway.
    Schmaier AH
    Curr Opin Hematol; 2016 Sep; 23(5):445-52. PubMed ID: 27380557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prekallikrein deficiency.
    Quail MT
    J Pediatr Oncol Nurs; 2013; 30(4):198-204. PubMed ID: 23629422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.